Last reviewed · How we verify
Pulsatile Oxytocin
At a glance
| Generic name | Pulsatile Oxytocin |
|---|---|
| Also known as | syntocinon |
| Sponsor | Ain Shams Maternity Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Continuous Oxytocin Infusion Versus Pulsatile Intravenous Oxytocin for Augmentation of First Stage of Labor (PHASE4)
- Investigating the Effect of Pulsatile Administration of Oxytocin on the Desensitization of Human Myometrium In-vitro (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pulsatile Oxytocin CI brief — competitive landscape report
- Pulsatile Oxytocin updates RSS · CI watch RSS
- Ain Shams Maternity Hospital portfolio CI